ilmscore | Emkay Pharmaceuticals Financials Predictions
N/A
Accuracy

Recent Predictions

Total: 2
Correct: 0
Incorrect: 0
Pending: 2
Prediction
Author
Predicted at
Status
Video
Emkay Pharmaceuticals (M Cure) expects its net debt to EBITDA ratio to improve in the medium term due to strong cash flow and appropriate capital spending management.
"M Cure expects this ratio to improve in the medium term as it expects its cash flow to remain strong..."
Jul 2, 2024
Pending
Emkay Pharmaceuticals (M Cure) expects its working capital cycle to be maintained.
"Working capital cycle will also be maintained"
Jul 2, 2024
Pending